Exploiting Therapy-Induced Senescence as an Evolutionary Double-Bind for Preventing Adaptive Resistance

Explore how therapy-induced senescence can be strategically exploited as an evolutionary double-bind mechanism to prevent adaptive resistance in cancer treatment through this 19-minute conference talk from Mathematical Oncology. Learn about innovative approaches that leverage cellular senescence as a therapeutic strategy, examining how cancer cells face evolutionary constraints when exposed to treatments that induce senescence. Discover the mathematical and biological principles underlying this double-bind scenario, where cancer cells must choose between immediate survival responses that may compromise long-term adaptability. Gain insights into how this evolutionary framework can inform the development of more effective cancer therapies that anticipate and counteract tumor evolution, potentially leading to improved treatment outcomes by limiting the cancer's ability to develop resistance mechanisms.